Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 08, 2019
Purdue has sold its Treyburn, North Carolina, plant to Novo Nordisk for an undisclosed sum, according to an announcement Purdue CEO Craig Landau sent to the plant’s employees.
read more
Wednesday, August 07, 2019
Late last week, a U.S. District Court judge in Washington, D.C. issued a decision that upheld FDA’s interpretation of clinical need regarding the bulk substances that may be used by outsourcing facilities in drug compounding.
read more
Wednesday, August 07, 2019
Applied DNA Sciences has announced the signing of a Master Services Agreement with Germany-based Schreiner Group through its Schreiner MediPharm business unit.
read more
Wednesday, August 07, 2019
Teva announced Michael McClellan, Executive Vice President and Chief Financial Officer (CFO), has decided to step down from his role as CFO due to personal reasons.
read more
Wednesday, August 07, 2019
Aevi has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18.
read more
Wednesday, August 07, 2019
Cambrex has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.
read more
Wednesday, August 07, 2019
Altasciences announced Dr. Beatrice Setnik, Ph.D. as Chief Scientific Officer, supporting internal and external clients.
read more
Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.
read more
CordenPharma Group announced the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective August 1, 2019.
read more
Omeros and Lonza announced a long-term manufacturing agreement for commercial production of narsoplimab, also referred to as OMS721.
read more
Amneal announced its Co-Founders, Chirag Patel and Chintu Patel, have been named Co-Chief Executive Officers, effective immediately.
read more
Pfizer announced the closing of its joint venture with GlaxoSmithKline to combine and create the world’s largest OTC business.
read more
Thursday, August 01, 2019
GVK BIO and BE Pharmaceuticals announced a strategic collaboration in drug product development.
read more
Thursday, August 01, 2019
Exelixis has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited.
read more
Thursday, August 01, 2019
Marken has announced the acquisition of PCX International based in Japan.
read more